Kennedy Eugene P. 4
4 · Galera Therapeutics, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Kennedy Eugene P.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-25+55,000→ 55,000 totalExercise: $1.78Exp: 2033-02-24→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.